Australia markets open in 9 hours 16 minutes

ContraVir Pharmaceuticals, Inc. (CTRVP)

OTC Markets OTCPK . Currency in USD
Add to watchlist
- (-)
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-38,520
-48,926
-42,200
-32,722
-20,354
-
Depreciation & amortisation
79.852
67.131
77.461
86.073
34.515
-
Deferred income taxes
-
-409.022
0
-
0
48.322
Stock-based compensation
115.328
1,340
2,553
4,669
2,379
-
Change in working capital
-2,213
2,971
3,153
-5,567
1,629
-
Other working capital
-36,305
-40,903
-34,978
-31,355
-16,253
-
Other non-cash items
1,309
-440
-414.992
2,310
140
-
Net cash provided by operating activities
-36,291
-40,889
-34,961
-31,224
-16,165
-
Cash flows from investing activities
Investments in property, plant and equipment
-
-14.304
-16.336
-130.405
-87.983
-
Net cash used for investing activities
-14.304
-14.304
-14.07
-130.405
-85.789
-
Cash flows from financing activities
Debt repayment
-
-
0
-176.585
0
-2,369
Common stock issued
-
-
0
82,154
42,866
7,684
Common stock repurchased
-
0
-21,000
0
-
-
Other financing activities
-
-
-2,000
-
-
-
Net cash used provided by (used for) financing activities
6,345
4,495
-5,137
81,977
43,055
-
Net change in cash
-29,888
-36,403
-40,160
50,622
26,804
-
Cash at beginning of period
42,993
51,189
91,349
40,727
13,923
-
Cash at end of period
13,033
14,786
51,189
91,349
40,727
-
Free cash flow
Operating cash flow
-36,291
-40,889
-34,961
-31,224
-16,165
-
Capital expenditure
-
-14.304
-16.336
-130.405
-87.983
-
Free cash flow
-36,305
-40,903
-34,978
-31,355
-16,253
-